Home
About IBT
Vision and Mission
IBT History
Management
Board of Directors
Advisory Board
Pipeline
IBP-9414
IBP-1016
Investors & Media
Shares
Share Issue
Ownership Structure
Presentations
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Contact Us
En
Sv
Home
About IBT
Vision and Mission
IBT History
Management
Board of Directors
Advisory Board
Pipeline
IBP-9414
IBP-1016
Investors & Media
Shares
Share Issue
Ownership Structure
Presentations
Corporate Governance
Calendar
Financial Reports
Press Releases
News
Investors & Media Contact
Contact Us
Press releases
Outcome of Infant Bacterial Therapeutics’ rights issue
To access the press release, please read the following disclaimer
here
.
February 2, 2018
Latest Press releases
Infant Bacterial Therapeutics AB (publ) announces that the Nomination Committee is appointed for the Annual General Meeting 2020
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – September 30, 2019
Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 – June 30, 2019
Infant Bacterial Therapeutics has recruited the first patient in the pivotal Phase III clinical study
FDA and Infant Bacterial Therapeutics agree on the design of Phase III study
This site uses cookies – small text-based files that are placed on your device to help us provide a better user experience.
Find out more.
Okay, thanks